Brief: Galecto Reports Third Quarter Results

Damora Therapeutics

08/11/2022 14:38

Nov 8 (Reuters) - Galecto Inc  GLTO.O :
    * GALECTO REPORTS THIRD QUARTER OPERATING AND FINANCIAL
RESULTS
    * GALECTO INC Q3 LOSS PER SHARE $0.54
    * GALECTO INC- INTERIM SAFETY DATA FROM PHASE 2A GALLANT-1
TRIAL
(NSCLC) BY Q1 2023
    * GALECTO INC- TOP-LINE RESULTS FROM PHASE 2B GALACTIC-1
TRIAL
(IPF) IN MID-2023

Source text for Eikon:  ID:nGNXxFHxc 
Further company coverage:  GLTO.O 
 ((reuters.briefs@thomsonreuters.com;))